Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pyxis Oncology, Inc. (PYXS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 32,761,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Pyxis Oncology is engaged in the development of therapeutics to treat cancers. Co. develops its product candidates to kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Co. has developed a portfolio of antibody drug conjugate product candidates and monoclonal antibody (mAb) preclinical discovery programs that it is developing as monotherapies and in combination with other therapies. Co.'s product candidates, PYX-201 and PYX-202 are in IND-enabling studies. In addition, PYX-203 is in preclinical development and it has additional preclinical mAb discovery programs.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 16,926 41,426 1,853,020
Total Buy Value $0 $31,503 $73,441 $5,073,440
Total People Bought 0 2 2 3
Total Buy Transactions 0 3 7 8
Total Shares Sold 0 0 36,558 1,782,319
Total Sell Value $0 $0 $81,462 $5,406,033
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 5 6
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 56
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Yanchik Connealy Pamela CFO and COO   •       –      –    2023-11-29 4 D $1.40 $51,729 D/D (36,949) 781,583     -
   Wadhane Jitendra Chief Accounting Officer   •       –      –    2023-11-15 4 A $0.00 $0 D/D 40,000 266,937     -
   Yanchik Connealy Pamela CFO and COO   •       –      –    2023-09-28 4 B $1.87 $14,960 D/D 8,000 818,532 2.74     -
   Yanchik Connealy Pamela CFO and COO   •       –      –    2023-09-27 4 B $1.85 $11,868 D/D 6,426 810,532 2.74     -
   Wadhane Jitendra Chief Accounting Officer   •       –      –    2023-09-27 4 B $1.87 $4,675 D/D 2,500 226,937 2.66     -
   Yanchik Connealy Pamela CFO and COO   •       –      –    2023-09-25 4 B $1.67 $20,044 D/D 12,000 804,106 2.74     -
   Wadhane Jitendra Chief Accounting Officer   •       –      –    2023-09-25 4 B $1.77 $8,850 D/D 5,000 224,437 2.74     -
   Wadhane Jitendra Chief Accounting Officer   •       –      –    2023-09-22 4 B $1.74 $4,349 D/D 2,500 219,437 2.66     -
   Yanchik Connealy Pamela CFO and COO   •       –      –    2023-09-22 4 B $1.74 $8,695 D/D 5,000 792,106 2.74     -
   Sullivan Lara President and CEO   •       •      –    2023-09-18 4 S $2.10 $17,936 D/D (8,541) 2,403,882     -
   Sullivan Lara President and CEO   •       •      –    2023-09-14 4 S $2.25 $225 D/D (100) 2,412,423     -
   Sullivan Lara President and CEO   •       •      –    2023-09-13 4 D $2.13 $393,500 D/D (184,742) 2,412,523     -
   Sullivan Lara President and CEO   •       •      –    2023-09-13 4 S $2.27 $6,816 D/D (3,000) 2,597,265     -
   Sullivan Lara President and CEO   •       •      –    2023-09-12 4 S $2.25 $11,071 D/D (4,917) 2,600,265     -
   Sullivan Lara President and CEO   •       •      –    2023-09-11 4 S $2.27 $45,414 D/D (20,000) 2,605,182     -
   Sullivan Lara President and CEO   •       •      –    2023-09-07 4 A $0.00 $0 D/D 469,483 2,625,182     -
   Yanchik Connealy Pamela CFO and COO   •       –      –    2023-09-07 4 A $0.00 $0 D/D 187,793 782,106     -
   Wadhane Jitendra Chief Accounting Officer   •       –      –    2023-09-07 4 A $0.00 $0 D/D 93,896 211,937     -
   Lewis-Hall Freda C Director   –       •      –    2023-03-24 4 A $0.00 $0 D/D 139,355 206,186     -
   Flavin John L Director   –       •      –    2023-03-24 4 A $0.00 $0 D/D 139,355 377,796     -
   Sullivan Lara President and CEO   •       •      –    2023-03-24 4 A $0.00 $0 D/D 703,379 2,155,699     -
   Humphrey Rachel Director   –       •      –    2023-03-24 4 A $0.00 $0 D/D 58,064 58,064     -
   Feingold Jay Chief Medical Officer   •       –      –    2023-03-24 4 A $0.00 $0 D/D 209,803 730,345     -
   Yanchik Connealy Pamela CFO and COO   •       –      –    2023-03-24 4 A $0.00 $0 D/D 209,803 594,313     -
   Wadhane Jitendra Chief Accounting Officer   •       –      –    2023-03-24 4 A $0.00 $0 D/D 74,393 88,648     -

  56 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed